TrademarkDir

I.D.M. IMMUNO-DESIGNED MOLECULES – Trademark Portfolio

Entity Type: 16

I.D.M. IMMUNO-DESIGNED MOLECULES holds 17 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 16 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 4 Nice Classification classes. The owner is based in F-75011 Paris.

172, rue de Charonne

F-75011 Paris , FR

17 Total Trademarks

Add to watchlist:

No watchlists yet
+ Create New Watchlist
Loading...
All (17) Abandoned (1) Cancelled (15)
By Date
By Name
Filter by Class:

Trademark Classifications

I.D.M. IMMUNO-DESIGNED MOLECULES's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (16 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

1
Chemicals (13 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

10
Medical Apparatus (5 filings)

Surgical, medical, dental and veterinary apparatus and instruments

42
Computer & Scientific (4 filings)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does I.D.M. IMMUNO-DESIGNED MOLECULES have?

I.D.M. IMMUNO-DESIGNED MOLECULES has 17 U.S. trademarks filed with the USPTO.

What trademark classes does I.D.M. IMMUNO-DESIGNED MOLECULES file in?

I.D.M. IMMUNO-DESIGNED MOLECULES files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is I.D.M. IMMUNO-DESIGNED MOLECULES's trademark registration success rate?

I.D.M. IMMUNO-DESIGNED MOLECULES has a 0% trademark registration rate, with 0 out of 16 resolved applications resulting in successful registration. Currently, 0 applications are pending review.